Post-acute COVID-19 syndrome after reinfection and vaccine breakthrough by the SARS-CoV-2 Gamma variant in Brazil

Int J Infect Dis. 2022 Jan:114:58-61. doi: 10.1016/j.ijid.2021.10.048. Epub 2021 Oct 29.

Abstract

We describe a case of prolonged COVID-19 caused by the SARS-CoV-2 Gamma variant in a fully vaccinated healthcare worker, 387 days after an infection caused by lineage B.1.1.33. Infections were confirmed by whole-genome sequencing and corroborated by the detection of neutralizing antibodies in convalescent serum samples. Considering the permanent exposure of this healthcare worker to SARS-CoV-2, the waning immunity after the first infection, the low efficacy of the inactivated vaccine at preventing COVID-19, the immune escape of the Gamma variant (VOC), and the burden of post-COVID syndrome, this individual would have benefited from an additional dose of a heterologous vaccine.

Keywords: COVID-19 breakthrough infection; SARS-CoV-2 variants; health personnel; post-acute COVID-19 syndrome; reinfection; whole-genome sequencing.

Publication types

  • Case Reports

MeSH terms

  • Brazil
  • COVID-19 Serotherapy
  • COVID-19* / complications
  • COVID-19* / therapy
  • Humans
  • Immunization, Passive
  • Post-Acute COVID-19 Syndrome
  • Reinfection
  • SARS-CoV-2*
  • Vaccines, Inactivated

Substances

  • Vaccines, Inactivated

Supplementary concepts

  • SARS-CoV-2 variants